Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FFH9P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,839
Award facts
- Contract value 100% obligated
- $19,839.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with a ceiling value of $19,839. This competitively awarded, firm fixed-price contract was finalized on December 12, 2025, with an ultimate completion date of January 6, 2026. The contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion value through December 2026 and serves as the primary pharmaceutical support vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its extensive portfolio of pharmaceutical products and medical supplies. The company's role as a critical vendor within the Defense Logistics Agency's medical supply chain positions it to support diverse military and veteran healthcare requirements. This particular delivery order for Varivax vaccine reflects the company's capability to supply vaccines and specialized medical commodities across multiple therapeutic domains, contributing to the broader pharmaceutical and medical supply needs of the Department of Defense and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFH9P?
SPE2DR26FFH9P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FFH9P worth?
The government has obligated $19,839 on SPE2DR26FFH9P.
Is contract SPE2DR26FFH9P an order under another contract?
Yes. SPE2DR26FFH9P is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH9P competed?
The extent of competition for SPE2DR26FFH9P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award